Collectively, SHP-2 can promote the development of HCC by their involvement in the proliferation and survival of tumor cells, but inhibition of SHP-2 in immune cells can suppress antitumor immunity. This evidence concerns the gene PTPN11 and hepatocellular carcinoma.